Regulation of endothelial production of C-type natriuretic peptide in coculture with vascular smooth muscle cells: Role of the vascular natriuretic peptide system in vascular growth inhibition

Circulation Research

Volumn 78, Issue 4, 1996, Pages 606-614

  Komatsu, Yasato ^a   Itoh, Hiroshi ^a   Suga, Shin Ichi ^a   Ogawa, Yoshihiro ^a   Hama, Norio ^a   Kishimoto, Ichiro ^a   Nakagawa, Osamu ^a   Igaki, Toshio ^a   Doi, Kentaro ^a   Yoshimasa, Takaaki ^a   Nakao, Kazuwa ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

cyclic GMP; endothelium derived relaxing factor; natriuretic peptide receptor; transforming growth factor

Indexed keywords

ATRIAL NATRIURETIC FACTOR ANTAGONIST; CYCLIC GMP; MESSENGER RNA; MONOCLONAL ANTIBODY; NATRIURETIC PEPTIDE TYPE C; NEUTRALIZING ANTIBODY; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ARTICLE; BIOASSAY; CATTLE; CELL COUNT; CELL CULTURE; CONTROLLED STUDY; ENDOTHELIUM; GROWTH INHIBITION; IMMUNOREACTIVITY; MALE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RAT; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

EID: 0029873116     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.78.4.606     Document Type: Article

References (40)

1. Sudoh T, Minamino N, Kangawa K, Matsuo H. C-type natriuretic peptide (CNP): a new member of natriuretic peptide family identified in porcine brain. Biochem Biophys Res Commun. 1990;168: 863-870.
2. Mukoyama M, Nakao K, Hosoda K, Suga S, Saito Y, Ogawa Y, Shirakami G, Jougasaki M, Obata K, Yasue H, Kambayashi K, Inouye K, Imura H. Brain natriuretic peptide as a novel cardiac hormone in humans: evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. J Clin Invest. 1991;87:1402-1412.
3. Komatsu Y, Nakao K, Suga S, Ogawa Y, Mukoyama M, Arai H, Shirakami G, Hosoda K, Nakagawa O, Hama N, Kishimoto I, Imura H. C-type natriuretic peptide (CNP) in rats and humans. Endocrinology. 1991;129:1104-1106.
4. Chinkers M, Garbers DL. Signal transduction by guanylyl cyclases. Annu Rev Biochem. 1991;60:553-575.
5. Koller KJ, Lowe DG, Bennett GL, Minamino N, Kangawa K, Matsuo H, Goeddel DV. Selective activation of the B natriuretic peptide receptor by C-type natriuretic peptide (CNP). Science. 1991;252:120-123.
6. Suga S, Nakao K, Hosoda K, Mukoyama M, Ogawa Y, Shirakami G, Arai H, Saito Y, Kambayashi Y, Inouye K, Imura U. Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide, and C-type natriuretic peptide. Endocrinology. 1992;130:229-239.
7. Komatsu Y, Nakao K, Itoh H, Suga S, Ogawa Y, Imura H. Vascular natriuretic peptide. Lancet. 1992;340:622.
8. Suga S, Nakao K, Kishimoto I, Hosoda K, Mukoyama M, Arai H, Shirakami G, Ogawa Y, Komatsu Y, Nakagawa O, Hama N, Imura H. Phenotype-related alteration in expression of natriuretic peptide receptors in aortic smooth muscle cells. Circ Res. 1992;71:34-39.
9. Stingo AJ, Clavell AL, Aarhus LL, Burnett JC. Cardiovascular and renal actions of C-type natriuretic peptide. Am J Physiol. 1992;262: H308-H312.
10. Igaki T, Itoh H, Suga S, Hama N, Ogawa Y, Komatsu Y, Mukoyama M, Sugawara A, Yoshimasa T, Tanaka I, Nakao K. C-type natriuretic peptide in chronic renal failure and its action in humans. Kidney Int. 1995. In press.
11. Suga S, Nakao K, Itoh H, Komatsu Y, Ogawa Y, Hama N, Imura H. Endothelial production of C-type natriuretic peptide and its marked augmentation by transforming growth factor-β: possible existence of vascular natriuretic peptide system. J Clin Invest. 1992; 90:1145-1149.
12. Itoh H, Pratt RE, Dzau VJ. Atrial natriuretic polypeptide inhibits hypertrophy of vascular smooth muscle cells. J Clin Invest. 1990;86: 1690-1697.
13. Furuya M, Yoshida M, Hayashi Y, Ohnuma N, Minamino N, Kangawa K, Matsuo H. C-type natriuretic peptide is a growth inhibitor of rat vascular smooth muscle cells. Biochem Biophys Res Commun. 1991;177:927-931.
14. Suga S, Itoh H, Komatsu Y, Ogawa Y, Hama N, Yoshimasa T, Nakao K. Cytokine-induced C-type natriuretic peptide (CNP) secretion from vascular endothelial cells: evidence for CNP as a novel autocrine/paracrine regulator from endothelial cells. Endocrinology. 1993;133:3038-3041.
15. Hama N, Itoh H, Shirakami G, Komatsu Y, Yoshimasa T, Tanaka I, Mori K, Nakao K. Detection of C-type natriuretic peptide (CNP) in human circulation and marked increase of plasma CNP level in septic shock patients. Biochem Biophys Res Commun. 1994;198: 1177-1182.
16. Ganz P, Davies PF, Leopold JA, Gimbrone MA, Alexander RW. Short- and long-term interactions of endothelium and vascular smooth muscle in coculture: effects on cGMP production. Proc Natl Acad Sci U S A. 1986;83:3552-3556.
17. 2+ levels in cultured vascular smooth muscle cells. J Biol Chem. 1989;264: 1146-1155.
18. Nadal-Ginard B. Commitment, fusion and biochemical differentiation of a myogenic cell line in the absence of DNA synthesis. Cell. 1978;15:855-864.
19. Saito Y, Nakao K, Mukoyama M, Shirakami G, Itoh H, Yamada T, Arai H, Hosoda K, Suga S, Jougasaki M, Imura H. Application of monoclonal antibodies for endothelin to hypertensive research. Hypertension. 1990;15:734-738.
20. Tso JY, Sun XH, Lao TH, Reece KS, Wu R. Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNAs: genomic complexity and molecular evolution of the gene. Nucleic Acids Res. 1985;13:2485-2502.
21. Hama N, Itoh H, Suga S, Komatsu Y, Yoshimasa T, Nakao K. A monoclonal antibody to C-type natriuretic peptide: preparation and application to radioimmunoassay and neutralization experiment. J Endocrinol. 1994;141:473-479.
22. Toki S, Morishita Y, Sano T, Matsuda Y. HS-142-1, a novel non-peptide ANP antagonist, blocks the cyclic GMP production elicited by natriuretic peptides in PC12 and NG108-15 cells. Neurosci Lett. 1992;135:117-120.
23. Itoh H, Mukoyama M, Pratt RE, Gibbons GH, Dzau VJ. Multiple autocrine growth factors modulate vascular smooth muscle cell growth response to angiotensin II. J Clin Invest. 1993;91:2268-2274.
24. Laurence DA, Pircher R, Kryceve-Martinerie C, Jullien P. Normal embryo fibroblasts release transforming growth factors in a latent form. J Cell Physiol. 1984;121:184-188.
25. Keski-Oja J, Lyons RM, Moses HL. Immunodetection and modulation of cellular growth with antibodies against native transforming growth factor-β. Cancer Res. 1987;47:6451-6458.
26. Orlidge AA, Saunders KB, Smith SR, D'Amore PA. An activated form of transforming growth factor β is produced by cocultures of endothelial cells and pericytes. Proc Natl Acad Sci U S A. 1989;86: 4544-4548.
27. Narahara N, Enden T, Wiiger M, Prydz H. Polar expression of tissue factor in human umbilical vein endothelial cells. Arterioscler Thromb. 1994;14:1815-1820.
28. Suga S, Nakao K, Mukoyama M, Arai H, Hosoda K, Ogawa Y, Imura H. Characterization of natriuretic peptide receptors in cultured cells. Hypertension. 1992;19:762-765.
29. Marczin N, Ryan US, Catravas JD. Endothelial cGMP does not regulate basal release of endothelium-derived relaxing factor in culture. Am J Physiol. 1992;263:L113-L121.
30. Palmer RMJ, Ashton ES, Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature. 1988;333:664-666.
31. Sato Y, Tsuboi R, Lyons R, Moses H, Rifkin DB. Characterization of the activation of latent TGF-β by co-cultures of endothelial cells and pericytes or smooth muscle cells: a self-regulating system. J Cell Biol. 1990;111:757-763.
32. Porter JG, Catalanor R, McEnroe G, Lewicki JA, Protter AA. C-type natriuretic peptide inhibits growth factor-dependent DNA synthesis in smooth muscle cells. Am J Physiol. 1992;263: C1001-C1006.
33. Garg UC, Hassid A. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of rat vascular smooth muscle cells. J Clin Invest. 1989;83: 1774-1777.
34. Cahill P, Hassid A. Differential antimitogenic effectiveness of atrial natriuretic peptides in primary versus subcultured rat aortic smooth muscle cells: relationship to expression of ANF-C receptors. J Cell Physiol. 1993;154:28-38.
35. Cahill PA, Hassid A. ANF-C-receptor-mediated inhibition of aortic smooth muscle cell proliferation and thymidine kinase activity. Am J Physiol. 1994;266:R194-R203.
36. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362:801-809.
37. Furuya M, Aisaka K, Miyazaki T, Honbou N, Kawashima N, Ohno T, Tanaka S, Minamino N, Kangawa K, Matsuo H. C-type natriuretic peptide inhibits intimai thickening after vascular injury. Biochem Biophys Res Commun. 1993;193:248-253.
38. 1 in cultured aortic smooth muscle cells. Hypertension. 1994; 23:908-913.
39. Bush H Jr, Jakubowski JA, Sentissi JM, Curl GR, Hayes JA, Deykin D. Neointimal hyperplasia occurring after carotid endarterectomy in a canine model: effect of endothelial cell seeding vs perioperative aspirin. J Vasc Surg. 1987;5:118-125.
40. Conte MS, Choudhry RP, Shirakowa M, Fallon JT, Birinyi LK. Endothelial cell seeding fails to attenuate intimai thickening in balloon-injured rabbit arteries. J Vasc Surg. 1995;21:413-421.